Table 1.
Model | Model function (biological process studied) | References |
---|---|---|
Macrophage | To evaluate drug delivery system targeting ability to plaque | (39) |
To evaluate drug delivery system effects on macrophage polarization | (40) | |
To evaluate drug delivery system effects on cholesterol removal (efflux) | (41–43) | |
To evaluate drug delivery system effects on inflammation resolution | (44–50) | |
To evaluate drug delivery system effects on Reactive oxygen species generation | (41, 47, 49, 51–54) | |
To evaluate drug delivery system effects on nitric oxide production | (52) | |
To evaluate drug delivery system effects on efferocytosis and phagocytosis | (55, 56) | |
To evaluate cellular uptake of drug delivery system | (41, 43, 44, 49, 55, 56) | |
To evaluate drug delivery system effects on cellular apoptosis | (49, 57) | |
To evaluate drug delivery system effects on foam cell formation | (41, 42, 46, 49, 57) | |
SMC | To evaluate drug delivery system effects on the cellular proliferation | (44) |
To evaluate drug delivery system effects on foam cell formation | (49, 58) | |
To evaluate the cellular uptake of drug delivery systems | (49) | |
EC | To evaluate the cellular uptake of drug delivery systems | (44) |
Foam cell | To evaluate cellular binding of drug delivery systems | (51) |
To evaluate drug delivery system effects on cholesterol removal (efflux) | (54) | |
To evaluate drug delivery system effects on inflammation resolution | (54) |